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Malignant Spinal Cord Compression (MSCC) is a particularly challenging area of cancer care where early diagnosis and expert
multiprofessional care and rehabilitation, are paramount in optimising quality of life. This audit reports data collected retrospectively
over a period of 12 months on patients with MSCC referred to the West of Scotland Cancer Centre (n¼174). It was carried out to
build on the work of the Clinical Resource and Audit Group (CRAG) and to examine current practice for symptom assessment,
multiprofessional care and rehabilitation of patients with MSCC admitted to the cancer centre. Areas of concern include poor
assessment of pain, the poor ambulatory status of patients on admission and the lack of clear plans for mobilisation and rehabilitation
for the majority of patients. Recommendations include the development of regional guidelines for referral, treatment and
rehabilitation, and the development of a pathway of care for use in all care settings across the region, together with improvements for
use in patient information, staff education, audit and research. These are now being taken forward through the West of Scotland
Cancer Network with dedicated funding from Macmillan Cancer Relief.
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Malignant spinal cord compression (MSCC) is a common
oncological emergency that requires prompt recognition and
immediate treatment to relieve pain and preserve neurological
function (Bucholtz, 1999). It can present at any time during the
natural history of a cancer (Bucholtz, 1999) and is a major cause of
morbidity in oncology patients (Husband et al, 2001). The effects
of MSCC can range from minor sensory, motor and autonomic
changes to severe pain and complete paralysis that significantly
affects a patient’s quality of life (Held and Peahota, 1993). In
patients with back pain and a history of cancer, a high degree of
suspicion is necessary to ensure an early diagnosis (Held and
Peahota, 1993).
Much has been written about the management of patients with
MSCC emphasising the importance of early diagnosis in maximis-
ing response to treatment and optimising patient outcomes (Held
and Peahota, 1993; Bucholtz, 1999; Quinn and DeAngelis, 2000). In
addition, the importance of a multidisciplinary approach to care is
considered to be of vital importance in the rehabilitation of
patients with MSCC (Held and Peahota, 1993; Hillier and Wee,
1997; Guo et al, 2003).
A national audit carried out in Scotland by the Clinical Resource
and Audit Group (CRAG) over 16 months from January 1998 to
April 1999, reported variations in care and suboptimal practices at
many stages of the patient journey both prior to and following a
diagnosis of MSCC (Levack et al, 2001, 2002). Despite these
findings and the resulting recommendations, patients continue to
present with advanced symptoms of MSCC and to experience
inappropriate variations in care. While Levack et al (2001) did
much to raise the profile of such a challenging area of cancer care
and provided helpful recommendations to address the shortfalls, it
is questionable whether these recommendations have been
followed and whether there has been any improvement in local
time to diagnosis, assessment of patient symptoms and treatment
delivery. The impetus for this audit came from the Research and
Practice Development Group (RPDG) within the cancer centre, to
build on the work of Levack et al (2001) and to examine current
practice for symptom assessment, multi-professional care and
rehabilitation of patients with MSCC admitted to the cancer centre.
PATIENTS AND METHODS
Sample
The study sample included patients with a diagnosis of MSCC
admitted to the cancer centre for treatment, over a 12-month
period from November 2001 to October 2002. These patients were
initially identified through liaison with the coding department and
included all patients coded with a diagnosis of spinal cord
compression or cauda equine syndrome. Patients who were
admitted more than once relating to the same spinal cord episode,
with either deterioration of their physical condition or for other
symptom management, were included in the audit for the acute
MSCC event only. A potential sample of 202 patients was initially
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sgenerated. The final sample number included in the audit was 174
patients, with a further 17 patients included for details on primary
cancer diagnoses (n¼191).
Patients were excluded from the audit if:
  They were coded as MSCC but on further review of the case-
notes did not have such a diagnosis although it had been
suspected (n¼11).
  It was not possible to obtain their case-notes within the
timeframe of the audit due to difficulty with access (n¼17).
Data collection and analysis
In consultation with key multiprofessional experts a questionnaire
was developed by the RPDG. Specific audit categories were
identified from review of the literature, discussion and reflections
on clinical practice. The audit questionnaire was piloted on 20
patient case records and refinements made to the design and
content prior to the development of an electronic data collection
tool which was created using Epi-Infot, 2003. Data was extracted
from the written documentation of all professional groups
involved in the care of these patients. This was analysed using
the Epi-Infot (2003) package and included basic descriptive
statistics.
RESULTS
Diagnosis
The commonest primary tumour diagnoses were lung (29%),
prostate (19%) and breast (13%). When combined, these
comprised 61% (117/191) of all cases of MSCC. A relatively high
incidence of MSCC, was also associated with either an unknown
primary site (14%) or haematological malignancies (10%). The
remaining 15% comprised of a further nine primary cancer
diagnoses.
Sites of compression
The thoracic spine was the most common site involved with 77%
of patients being affected. A further 29% occurred in the lumbar
region, 12% in the cervical region and 7% in the sacral region.
Twenty-five percent of patients were identified as having MSCC in
more than one area of the spine.
Source of referral
Patients were admitted to the cancer centre from a wide variety of
health care settings and routes throughout the region. These can be
split into two categories; those coming from the hospital setting
(DGH and hospice) and those coming direct to the cancer centre
from the community (GP, A/E, home and cancer centre clinic) as
shown in Figure 1. As would be expected, the majority of patients
(94%) were admitted to the cancer centre as an emergency.
Magnetic resonance imaging/computerised tomography
scanning
All patients had a magnetic resonance imaging (MRI) or
computerised tomography (CT) scan to confirm diagnosis with
the exception of one patient. In all, 58% had an MRI scan following
admission to the cancer centre, while 36% had an MRI scan and
6% had a CT scan prior to being referred. The time interval
between scanning and admission to the cancer centre is shown in
Table 1. The majority of patients (67%) had their scan performed
within 1 day either side of admission.
Treatment
The majority of patients (93%) received palliative radiotherapy;
4% were treated with chemotherapy; 3% received surgery to treat
their compression and 4% received supportive care alone, specific
to presenting clinical symptoms. A small number of patients (4%)
were treated with more than one treatment modality.
Although only 3% of patients received surgery to treat their
compression the actual number referred for a surgical opinion
following admission to the cancer centre was 7%.
Of the patients who received radiotherapy, 93% had one area of
the spine treated and the remaining 7% had treatment to either two
or three sites. Table 2 demonstrates the time interval between the
MRI or CT scan being carried out and radiotherapy commencing.
Most patients (61%) began radiotherapy either the same day or
within 1 day of the MRI scan.
Steroid therapy
From examination of medical and nursing letters from transferring
hospitals and referring GP’s, it was possible to identify if steroids
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Figure 1 Source of referral to the cancer centre.
Table 1 Time interval between MRI/CT scan and cancer centre
admission
MRI/CT scan %
41 day prior to admission 11
1 day prior to admission 28
Same day as admission 24
1 day after admission 15
2 days after admission 5
3 days after admission 2
4 days after admission 2
44 days after admission 10
Unknown data 3
Total 100
Table 2 Time interval between MRI/CT scan and radiotherapy
commencing
Radiotherapy commenced %
Prior to scan 1.5
Same day as scan 25
1 day after scan 36
2 days after scan 15
3 days after scan 4
4 days after scan 0.5
44 days after scan 13
Unknown data 4
Total 100
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shad been prescribed prior to admission to the cancer centre. In
42% of cases, dexamethasone had been prescribed prior to cancer
centre admission and this increased to 96% following admission. A
dose of 16mg per day was prescribed for 95% of the sample.
Mobility
The ambulatory status of patients on admission and discharge is
shown in Figure 2. At time of admission, only 9% of patients were
able to walk independently without aid, 44% with aid of a walking
stick, walking frame or assistance of another individual and 47%
were unable to walk. Of the 159 patients who were discharged from
the cancer centre, 7% were walking independently, 33% were
walking with aid and 60% were unable to walk.
From the case records it was identified that on admission to the
cancer centre, the majority of patients (86%) were initially nursed
in a supine position on ‘bed rest’ and 3% remained ambulant. For
11% it was not possible to ascertain from either nursing or medical
notes if restrictions were imposed regarding mobility. A plan of
incremental movement was documented for 33%; the content of
this varied from no plan to a structured plan located in the
physiotherapy notes. Case records were examined to establish
whether preventative measures had been taken against the
development of thrombosis due to immobility. Antiembolic
stockings were worn by 67% of patients and prophylactic
anticoagulant therapy was prescribed for 35%.
Pain assessment
Nearly all patients (98%) had a degree of pain at time of admission
to the cancer centre. The site of pain was documented for 73% of
patients with 25% having no site of pain mentioned and 2%
documented to have ‘no pain’. A pain score was reported for 37%
of patients with 24% having this reassessed following initial
assessment.
Bladder and bowel function
A total of 66% of patients’ required urinary catheterisation either
for the management of urinary incontinence or urinary retention.
In all, 32% had a catheter inserted prior to admission to the cancer
centre and 34% following admission. There was documented
evidence in the case-notes suggesting symptoms of constipation
for 60% of patients on admission.
Referral to physiotherapist and occupational therapist
The majority of patients (94%) were referred to the physiotherapy
team with most referrals made within one day of admission (60%).
In contrast, 18% were referred to occupational therapy, with the
majority (55%) being referred X7 days following hospital
admission.
Discharge location
The majority of patients (60%) were referred back to a DGH on
discharge from the cancer centre. A further 17% were discharged
to a hospice and the remaining 23% were discharged home.
Survival/outcomes
Survival data was collected from case records and via the local
electronic case management system. This identified that 15
patients (8.6%) died during their admission period in the cancer
centre. Within 3 months (90 days) of admission, 74% of the audit
population were known to be deceased.
DISCUSSION
Results have been reported in relation to a variety of aspects of
clinical care, as well as demographic and referral patterns for
patients with MSCC. Much of the data is consistent with that
reported in the literature, however, evidence is lacking in relation
to some areas of practice and this is reflected in the results which
will now be discussed.
Diagnoses and sites of compression for patients in this audit are
consistent with findings from the prospective audit conducted by
the Clinical Resource and Audit Group (CRAG) in Scotland
(Levack et al, 2001) and a literature review by Loblaw and
Laperriere (1998). Patients with lung, prostate and breast cancer
had a higher incidence of MSCC, with the thoracic spine being the
most common site affected.
MRI scanning of the entire spine is the investigation of choice in
patients with known malignancy and suspected spinal canal
disease (Cook et al, 1998; Loughrey et al, 2000; Husband et al,
2001; Levack et al, 2001). Less than half of the patients in this study
had an MRI or CT scan prior to admission to the cancer centre.
Levack et al (2001) similarly, found substantial delays from time of
presenting symptoms to definitive radiological diagnosis with an
MRI or CT scan. However, it is acknowledged that access to MRI
and CT imaging is mainly confined to larger healthcare settings
and that clinical demand often exceeds availability, resulting in
some delay even when the scan is urgent. Further work is required
to determine where specific delays are encountered and where
improvements can be made.
Urgent referral and treatment of MSCC is essential to maximise
prognosis and treatment outcomes (Markman, 1999). Our data
shows that two thirds of patients received their scan within 24h
either side of admission to the cancer centre, which indicates the
urgency with which these patients were referred for diagnosis.
It is suggested that initial presentation direct to a cancer centre
is associated with reduced delay in time to treatment and
improved neurological function (Husband, 1998). Husband
(1998) strongly advises that patients who have back pain and a
diagnosis of cancer be referred urgently or to be encouraged to self
refer to the cancer centre. Several authors have advocated that the
rate of early diagnosis and prevention of potential paralysis could
be improved if oncology patients were taught the importance of
contacting health care providers with complaints of pain,
especially when the pain is accompanied by neurological signs
and symptoms (Peterson, 1993; Husband, 1998; Bucholtz, 1999).
Currently, there is no system in place within the cancer centre, to
inform or educate patients on the early warning signs of MSCC
that would alert them to present earlier. Since MSCC occurs in only
a small percentage of patients it could be considered reasonable to
target patient education to those at high risk, for example those
with breast, lung and prostate cancer with bone metastases
(Husband, 1998).
Palliative radiotherapy was the treatment of choice for 94% of
patients presenting with MSCC, which is consistent with published
literature (Quinn and DeAngelis, 2000). Very few patients were
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Figure 2 Ability to walk on cancer centre admission and discharge.
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sreferred for surgical opinion (7%) from the cancer centre with
even fewer undergoing surgery (3%). While this audit did not
detect patients referred directly to surgery from a DGH for surgery
alone it will have captured patients referred in this manner, who
received adjuvant radiotherapy postsurgery.
The low rate of surgical referral could be due to unclear referral
pathways to orthopaedic and neurosurgical expertise. This needs
to be addressed particularly in light of the Patchell et al (2003)
study, which showed that patients who were randomised to receive
surgery (within 24h of presentation) followed by radiotherapy
(within 14 days) retained the ability to walk significantly longer
than those treated with radiotherapy alone. Length of survival was
not significantly different between the two groups, although there
was a trend towards longer survival time in the surgery group.
Those treated with surgery and radiotherapy walked for almost all
their remaining life while those treated with radiotherapy alone
were nonambulatory.
The time interval between MRI/CT scan and radiotherapy
commencing was calculable for 156 of the 163 patients who
received radiotherapy. In 63% of patients, radiotherapy was
commenced on either the same day or within 1 day of the MRI
scan. However, 22 patients did not commence radiotherapy until 5
days or more after their MRI/CT scan being performed. Data was
not collected on reasons for delays to treatment and this needs
further investigation in order to eliminate avoidable causes.
Steroids are an effective adjunct to radiotherapy, reducing spinal
cord oedema and inflammation and improving neurologic deficits
and pain control (Held and Peahota, 1993; Maranzano et al, 1996;
Bucholtz, 1999; Quinn and DeAngelis, 2000). Based on patients’
signs and symptoms and a high index of suspicion for MSCC,
steroid administration should be initiated prior to the completion
of all necessary diagnostic tests (Bucholtz, 1999; Quinn and
DeAngelis, 2000). Less than half of the patients appeared to have
been prescribed dexamethasone prior to admission to the cancer
centre. However, documentation received from referring DGHs
and community sources did not always include information on the
commencement of steroid therapy. Steroid therapy could have
been initiated earlier in some patients prior to diagnosis, however,
fair evidence exists suggesting that steroids do not have to be given
routinely where a patient has good motor function at time of
presentation, (Maranzano et al, 1996). It is common practice in the
UK for 16mg of Dexamethasone to be prescribed per day for
MSCC (Levack et al, 2001). Ninety-five percent of patients in this
audit received this dose.
Ambulatory status on admission was very similar to figures
reported for this cancer centre in the audit by Levack et al (2001).
This demonstrates that after four and a half years (time between
data collection for the two audits), patients continue to be referred
to the cancer centre with advanced symptoms of MSCC. It was also
disappointing to see that ambulatory status of the group was
generally worse on discharge with more patients being unable to
walk. In some cases this could be the result of delays in time to
diagnosis and referral for treatment, leading to poorer treatment
outcomes. It is acknowledged, however, that data in relation to
ambulatory status on discharge should be interpreted with caution,
since it was difficult to obtain an objective picture from
documentation in the case notes. Mobility was often poorly
documented and assessed differently by different health care
professionals.
It is standard practice for patients with MSCC at the cancer
centre to be placed on bed rest, in a supine position, until stability
of the patients’ spine is established and the treatment plan
instigated. It was apparent from the audit that in the majority of
cases there was no clear plan for individual patient mobilisation or
guidance regarding positioning. This may have resulted in some
patients lying supine for unnecessary and indefinite periods of
time. A plan for incrementally increasing movement was found in
the case records for only one third of patients. There appears to be
a vacuum of evidence in the literature regarding appropriate
positioning and optimal programmes for incremental movement
in patients with MSCC. Jacobs (1999) suggests that some patients
such as those who have a short life expectancy and those who have
been paralysed for more than 24h, would derive greater benefit
from sitting up and reducing their risk of complications from bed
rest. Further research is desperately needed to clarify practice in
this area and to establish the true cost in terms of the
complications associated with enforced bed-rest (Jacobs, 1999).
It is recognised that thrombosis is a common complication of
malignancy (Arkel, 2000) and that patients with spinal cord injury
are at risk of deep venous thrombosis (Chiou-Tan et al, 2003). The
Scottish Intercollegiate Guidelines Network (SIGN) in their
National Clinical Guideline – Prophylaxis of Venous Thromboem-
bolism (VTE) (SIGN 62) recommends that all patients admitted to
hospital with an acute medical illness that is likely to require bed
rest for 3 days or more, should be individually assessed for risk of
VTE (SIGN 62, 2002). Many patients with MSCC fall into this
category. In the absence of any contraindications, leg exercises and
the wearing of above knee graduated elastic compression stockings
(GECS) are recommended as VTE prophylaxis (SIGN 62, 2002).
While the audit findings suggest antiembolic stockings to be the
most common measure used for the prevention of thrombosis
development, it was not documented why one third of patients did
not have these fitted. While 35% of patients had prophylactic
anticoagulant therapy prescribed, further research is necessary to
determine the role of prophylactic anticoagulant therapy in
patients with MSCC.
Nearly all patients had pain at the time of admission to the
cancer centre, with 3/4 having the location documented. SIGN, in
their National Clinical Guideline – Control of Pain in Patients with
Cancer – advocate that prior to the treatment of pain, an accurate
assessment should be performed to determine the type and
severity of pain and it’s effect on the patient (SIGN, No 44, 2000).
Disappointingly, despite a pain assessment tool being available,
just over one third of patients had their pain assessed and a pain
score documented. Even fewer had this pain reassessed during
hospitalisation. This does not suggest that patients were not having
their pain managed but it does question whether this was being
carried out systematically or effectively.
Bowel and bladder incontinence develop with advanced
autonomic nervous system involvement and carries a poor
prognosis (Held and Peahota, 1993). Two thirds of patients
required a urinary catheter for the management of urinary
incontinence and retention. This is substantially higher than the
36% reported by Levack et al (2001). This highlights the late stage
of presentation and the need for earlier diagnosis and treatment,
before bladder function is affected. It is not surprising that so
many patients (67%) in this audit were found to have symptoms of
constipation on admission, as this is a common problem in
patients with spinal cord compression or cauda equina syndrome
(Fallon and O’Neill, 1997).
Effective rehabilitation is an important part of the management
of spinal cord compression secondary to advanced malignancy and
requires the diverse skills of all members of the multidisciplinary
team (Hillier and Wee, 1997). Referral should be made when the
patient is initially diagnosed with MSCC (Guo et al, 2003). Most
patients were referred for physiotherapy assessment, which was
usually carried out within 1 day of admission. It was surprising to
find that so few patients were referred to occupational therapy and
that in the majority of cases, referral was made at least 7 days after
admission. It is not clear why so few patients were referred and
why referrals were made so late. An awareness of the service and
importance of referral is needed to reverse this trend. Referral
criteria and guidelines may assist this process.
A large number of patients were discharged back to their local
DGH following treatment in the cancer centre with patients also
discharged back to hospice and home care settings. This
Malignant spinal cord compression audit
A McLinton and C Hutchison
489
British Journal of Cancer (2006) 94(4), 486–491 & 2006 Cancer Research UK
C
l
i
n
i
c
a
l
S
t
u
d
i
e
semphasises the need for MSCC management to be consistent in all
care settings across the region to ensure appropriate rehabilitation
and symptom control.
A total of 74% of the audit population died within 3 months of
their hospital admission, which reflects the poor prognosis of this
patient group. If patients with MSCC are to have improved quality
of life and extended survival, it is without doubt that current delays
in the patient journey require to be tackled in order to improve
this statistic.
While the audit has provided useful data in relation to referral,
treatment and management of MSCC, it must be acknowledged
that data was collected retrospectively and in some cases was
incomplete. It relies on accuracy of documentation and therefore,
in some cases may not provide a complete account of the care
provided.
Recommendations
This audit has identified important areas for practice development,
research and education for the whole multiprofessional team in
relation to the management of patients with MSCC and beyond.
Many areas that have been highlighted may not be unique to this
particular cancer centre and lessons can be learned to improve
practice and processes in other care settings where patients with
MSCC are treated.
Recommendations are summarised below:
  Development and implementation of local and regional guide-
lines for the referral, management and rehabilitation of patients
with suspected or diagnosed MSCC. This should be done as a
network-commissioned piece of work involving all stakeholders
and full consultation, based on existing evidence, best practice
and taking into account local provision and access to resources.
Guidelines would need to be introduced with an extensive
education programme to raise awareness and optimise future
compliance.
  Development and implementation of a pathway of care for
multiprofessional use across the region, to support the guide-
lines, and promote consistency and equity of care, regardless of
care setting. This would also help to facilitate communication
internally within the cancer centre and externally with both
primary and secondary care.
  Development of local and regional education programmes to
correct deficits in knowledge and clinical practice. The
information needs of stakeholders such as GP’s and general
physicians will also require to be addressed if appropriate
referral to the cancer centre is to be achieved. This could be
done by developing a core presentation covering the key issues
and linking it to existing programmes such as the educational
aspect of the Gold Standards Framework (Thomas, 2003) in
primary care.
  Patient information:
* Development of MSCC-specific patient information in
collaboration with national voluntary agencies such as
CancerBACUP to be given to patients with a diagnosis of
MSCC.
* Improvement in consistency of cancer site-specific informa-
tion in relation to MSCC for high-risk cancer groups, which
could be done through Cancer Managed Clinical Networks.
  Research strategy to address gaps in evidence such as;
* Ambulation/rehabilitation and rationale of nursing patients
in a supine position, the duration of this and the cost in terms
of complications.
* Effect on time to diagnosis/ambulatory status/outcomes of
direct referral to a cancer centre.
* DVT prophylaxis in patients with MSCC.
  Establishment of a core data set in collaboration with ISD for
future prospective audit.
These recommendations are now being taken forward through
the Regional Cancer Network as an 18-month project with
dedicated funding from Macmillan Cancer Relief.
CONCLUSIONS
Care of patients with MSCC is complex and involves multi-
professional expertise. Several recommendations have been pre-
sented around the areas of guideline development, documentation,
multiprofessional education, patient information, research and
audit which if addressed, will help to ensure that patients with
MSCC receive appropriate quality care and management that is
based on available evidence and best practice.
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